Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | STAT3 | P40763 | 9/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | IL2 | P60568 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425792 | 0.91 | STAT3 (0.41) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL29373472 | 0.89 | MAPT (0.49) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL29426112 | 0.85 | MAPT (0.51) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL29425802 | 0.80 | STAT3 (0.52) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL29374383 | 0.79 | STAT3 (0.42) | MAPTSTAT3MEN1KMT2APOLB | |
| Asperulosidic Acid SCHEMBL29459346 | 0.72 | MAPT (0.52) | MAPTSTAT3MEN1KMT2APOLB | |
| Asperulosidic Acid SCHEMBL422107 | 0.72 | MAPT (0.52) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL31228947 | 0.72 | PTPN1 (0.57) | MAPTPTPN1 | |
| SCHEMBL24305979 | 0.70 | MAPT (0.52) | MAPTSTAT3MEN1KMT2APOLB | |
| SCHEMBL24305717 | 0.70 | MAPT (0.54) | MAPTSTAT3MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |
| EP-3409766-A1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N-Zyme BioTec GmbH (DE) | 2018-12-05 | — | — | EP | disclosed |
| US-20150086655-A1 | Morinda Citrifolia Juice Formulations Comprising Iridoids | WEST BRETT JUSTIN (US) | 2015-03-26 | — | — | US | disclosed |
| US-8790727-B2 | Morinda citrifolia and iridoid based formulations | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-8679550-B2 | Morinda citrifolia juice formulations comprising iridoids | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120328720-A1 | Iridoid Based Formulations | MORINDA, INC. | 2012-12-27 | — | — | US | disclosed |
| US-20120021079-A1 | Garcinia Mangostana L. and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2012-01-26 | — | — | US | disclosed |
| US-20110217394-A1 | Iridoid Based Formulations | WEST BRETT JUSTIN | 2011-09-08 | — | — | US | disclosed |
| WO-2011106432-A2 | MORINDA CITRIFOLIA AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106423-A2 | ACAI AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106417-A2 | GARCINIA MANGOSTANA L. AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106448-A2 | IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110206786-A1 | Acai and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2011-08-25 | — | — | US | disclosed |
| US-20110206787-A1 | Morinda Citrifolia and Iridoid Based Formulations | MORINDA, INC. | 2011-08-25 | — | — | US | disclosed |